Insider · CIK 0001545794

Verwiel Frank

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001545794

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+9,200 sh	—	—	35,148
2026-06-09	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,300
2025-06-11	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+8,000 sh	—	—	25,948
2025-06-11	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,450
2024-06-17	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−1,505 sh	$25.00	−$37.6K	17,948
2024-06-12	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+7,737 sh	—	—	19,453
2024-06-12	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,515
2023-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+4,425 sh	—	—	11,716
2023-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,473 sh	—	—	6,473
2022-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+5,197 sh	—	—	7,291
2022-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,688 sh	—	—	7,688
2021-06-23	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+2,094 sh	—	—	2,094
2021-06-23	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,382 sh	—	—	3,382
2020-06-18	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42K sh	—	—	0
2019-05-21	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2019-01-23	ACHILLION PHARMACEUTICALS INCStock Option (Right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2018-05-17	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2018-05-15	AveXis, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,106 sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.5K sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,454 sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,905 sh	—	—	0
2018-03-13	AveXis, Inc.A Award	Director	AAward	+1,106 sh	—	—	1,106
2018-03-13	AveXis, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+2,905 sh	—	—	2,905
2018-02-09	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2017-07-25	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+38K sh	—	—	38,000
2017-05-30	AveXis, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+2,454 sh	—	—	2,454
2017-01-19	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2016-02-10	AveXis, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,111
2016-02-10	AveXis, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,385 sh	—	—	8,385
2016-01-25	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-12-14	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2014-09-29	INTERMUNE INCD Disposition to Issuer	Director	DDisposition to Issuer	−9,725 sh	$74.00	−$720K	0
2014-09-29	INTERMUNE INCRestricted stock unitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2014-09-29	INTERMUNE INCStock options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2014-09-29	INTERMUNE INCStock options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2014-09-29	INTERMUNE INCStock options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2014-09-29	INTERMUNE INCStock options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2013-05-30	INTERMUNE INCRestricted Stock UnitsA Award	Director	AAward	+3,000 sh	—	—	3,000
2013-05-30	INTERMUNE INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2012-06-04	INTERMUNE INCA Award	Director	AAward	+2,500 sh	$10.10	+$25.3K	6,725
2012-06-04	INTERMUNE INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2012-04-06	INTERMUNE INCA Award	Director	AAward	+3,600 sh	—	—	3,600
2012-04-06	INTERMUNE INCA Award	Director	AAward	+625 sh	—	—	4,225
2012-04-06	INTERMUNE INCStock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2012-04-06	INTERMUNE INCStock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500

Recent filings

Accepted (ET)
Jun 104
Verwiel Frank0001545794-26-000001
SEC(opens sec.gov)
Jun 134
Verwiel Frank0000950170-25-086287
SEC(opens sec.gov)
Jun 204
Verwiel Frank0000950170-24-075718
SEC(opens sec.gov)
Jun 144
Verwiel Frank0000950170-24-073704
SEC(opens sec.gov)
Jun 164
Verwiel Frank0001209191-23-037898
SEC(opens sec.gov)
Jun 164
Verwiel Frank0001209191-22-037604
SEC(opens sec.gov)
Jun 254
Verwiel Frank0001209191-21-043385
SEC(opens sec.gov)
Jun 194
Verwiel Frank0001209191-20-037971
SEC(opens sec.gov)
Jan 294
Verwiel Frank0001562180-20-000678
SEC(opens sec.gov)
May 224
Verwiel Frank0001209191-19-032086
SEC(opens sec.gov)
Jan 254
Verwiel Frank0001209191-19-005384
SEC(opens sec.gov)

Companies

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139